Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index; 95 of the 246 sources its claims cite were checked for support.

Hypothyroidism

Open access
Taylor, Peter N, Medici, Marco M, Hubalewska-Dydejczyk, Alicja, Boelaert, Kristien · 2024 · The Lancet

Abstract

Hypothyroidism, the deficiency of thyroid hormone, is a common condition worldwide. It affects almost all body systems and has a wide variety of clinical presentations from being asymptomatic to, in rare cases, life threatening. The classic symptoms of hypothyroidism include fatigue, lethargy, weight gain, and cold intolerance; however, these symptoms are non-specific and the diagnosis is typically made on biochemical grounds through serum thyroid function tests. The most common cause of hypothyroidism is chronic autoimmune thyroiditis (Hashimoto's thyroiditis), although other causes, including drugs (such as amiodarone, lithium, and immune checkpoint inhibitors), radioactive-iodine treatment, and thyroid surgery, are frequent. Historically, severe iodine deficiency was the most common cause. Reference ranges for thyroid function tests are based on fixed percentiles of the population distribution, but there is increasing awareness of the need for more individualised reference intervals based on key factors such as age, sex, and special circumstances such as pregnancy. Levothyroxine monotherapy is the standard treatment for hypothyroidism; it is safe and inexpensive, restores thyroid function tests to within the reference range, and improves symptoms in the majority of patients. However, 10% of patients have persistent symptoms of ill health despite normalisation of thyroid function tests biochemically and a substantial proportion of patients on levothyroxine have thyroid-stimulating hormone concentrations outside the reference range. Ongoing symptoms despite levothyroxine treatment has led to some patients using liothyronine or desiccated thyroid extract. Taken together, these factors have led to intense debate around the treatment thresholds and treatment strategies for hypothyroidism. In this Seminar, we review the epidemiology, genetic determinants, causes, and presentation of hypothyroidism; highlight key considerations and controversies in its diagnosis and management; and provide future directions for research.

Overview

CoChat Summary

TL;DR

This Lancet Seminar reviews hypothyroidism epidemiology, genetic determinants, causes, presentation, diagnosis, and management, emphasizing that it is largely a biochemical diagnosis and levothyroxine remains standard therapy. It highlights persistent controversies around treatment thresholds, individualized reference ranges, and management of patients with residual symptoms despite biochemical euthyroidism.

Key findings

  • In iodine-sufficient countries, overt hypothyroidism prevalence is approximately 1–2%; hypothyroidism (subclinical and overt) is about 10-times more common in women than men, and prevalence reaches as high as 7% in individuals aged 85–89 years when age-related reference ranges are not used.
  • Hashimoto’s thyroiditis is the most common cause; TPO-Ab are present in approximately 11% of the general population, twin studies estimate ~65% of variance is genetic, and a polygenic risk score in the highest vs lowest quartile was associated with subclinical hypothyroidism (OR 1.80, 95% CI 1.27–2.55) and overt hypothyroidism (OR 1.89, 95% CI 1.24–2.87).
  • Levothyroxine monotherapy is standard, but 25–40% of patients on long-term treatment have TSH below or above the reference range; 10–15% express dissatisfaction despite TSH normalization, and systematic reviews/meta-analyses of 18 trials found no clear benefit of combination levothyroxine-liothyronine over monotherapy.
  • Iatrogenic hypothyroidism is frequent: after radioactive iodine for Graves’ disease, hypothyroidism occurred in 80.7% within 12 months; lithium causes overt hypothyroidism in 5–15%; tyrosine kinase inhibitors led up to 27% requiring levothyroxine; external-beam radiotherapy for head and neck cancers has incidence around 20–30%.

Methods

  • Design: narrative Seminar/review synthesizing epidemiology, genetic determinants, causes, presentation, diagnosis, and management of hypothyroidism; not a systematic review or meta-analysis.
  • Data/sample: published literature, guidelines, population studies, genetic studies, RCTs, and meta-analyses; the contribution statement says PNT and MMM performed the literature search and all authors selected studies and drafted sections.
  • Analysis: narrative synthesis with selected quantitative estimates and guideline recommendations; no formal pooled analysis reported.

Limitations

  • Stated: evidence on subclinical hypothyroidism treatment is uncertain, with no definitive trial in younger individuals; observational studies are susceptible to confounding, reverse causation, and other biases; combination levothyroxine-liothyronine trials had small sample sizes, inadequate liothyronine dosing, often did not enroll patients with persistent symptoms despite biochemical euthyroidism, and did not use latest thyroid-specific outcome measures such as ThyPRO.
  • Stated: current polygenic risk scores for thyroid function are too limited by discriminatory power for clinical practice.
  • Evident: as a narrative Seminar, it does not report a systematic search strategy, formal study selection, risk-of-bias assessment, or quantitative synthesis, so recommendations rely on narrative interpretation of heterogeneous evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(24)01614-3

Cites

205 of 205 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

72 Valid · 7 Not valid · 91 Not checked · 13 Own results and interpretations

80 more claims · 35 with their cited sources checked

Create a free account to see all 183 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 70
  • Probably not a substantial claim. 43

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 203 references

Research works printed but not linked: 3

  1. Hashimoto, 1912, Zur Kenntniss der lymphomatosen Verandererung der Schilddrüse (Struma lymphomatosa), Arch Klin Chirugie, 97, 219
  2. Meyerovitch, 2007, Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians, JAMA, 167, 1533
  3. Garber, 2012, Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association, Endocr Pract, 18, 988, 10.4158/EP12280.GL · DOI · Paper page

Cited by

See all 128

Metadata

Authors
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K.
Affiliations
  • Cardiff University (GB)
  • Erasmus MC (NL)
  • University of Birmingham (GB)
Venue
The Lancet
Publisher
Elsevier BV
Published
2024-10
Volume
404
Issue
10460
Pages
1347-1364
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4403094217
Cited by
128
References
203
Citations by year
2026: 59 · 2025: 66 · 2024: 2
FWCI
31.13
Type
journal article
Language
en
Open access
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
hypothyroidism, thyroid hormone deficiency, Hashimoto's thyroiditis, autoimmune thyroiditis, drug-induced hypothyroidism, thyroid surgery, iodine deficiency, thyroid function tests
MeSH terms
Female, Humans, Hypothyroidism, Pregnancy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypothyroidism. https://app.cochat.ai/papers/10.1016/s0140-6736(24)01614-3
The paper
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024). Hypothyroidism. The Lancet. https://doi.org/10.1016/s0140-6736(24)01614-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.